EMCDDA–Europol 2017 Annual Report on the implementation of Council Decision 2005/387/JHA
Introduction
This report presents the key activities performed by the EMCDDA and Europol in 2017 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, including new psychoactive substances notified in 2017, Joint Reports produced, risk assessments conducted and public health-related alerts and advisories issued to the EU Early Warning System Network.
Download as PDF
Table of contents
- Background to this report
- Overview
- Implementation arrangements and cooperation with the European Union Pharmacovigilance system
- Specific implementation arrangements
- Assistance to national early warning systems
- Annual meeting of the EU Early Warning System Network
- Strengthening early warning and response
- Links with forensic science and toxicology networks
- Supporting activities and cooperation with third countries
- Cooperation with international organisations
- Europol
- Cooperation with the European Medicines Agency and the pharmacovigilance system
- New legislation
- Cooperation with ECHA, EFSA and ECDC
- Specific implementation arrangements
- Core activities
- Early warning activities (Article 4)
- New psychoactive substances detected and formally notified in 2017
- Reporting tools and 2016 seizure data
- Public health-related alerts
- EMCDDA–Europol Joint Reports (Article 5)
- Risk assessments (Article 6)
- Early warning activities (Article 4)
- Conclusions
- Publications
- Annex 1. New psychoactive substances notified for the first time in 2017 under the terms of Council Decision 2005/387/JHA
- Annex 2. List of risk communications issued to the EU Early Warning System Network in 2017 under the terms of Council Decision 2005/387/JHA
Pages:
31
Price:
Free
ISBN:
978-92-9497-348-1
ISSN:
1977-7841
Pub. DOI:
10.2810/759319
Catalog Number:
TDAN18001ENN
Main subject
Target audience